Specifically, we determined CDC42 expression levels in human MDA-MB-231 triple-negative breast cancer cells before and after metformin exposure and observed a striking down regulation of CDC42 expression in the presence of metformin (Figure 3A). Here, CDC42 is linked to triple-negative breast carcinoma.